Answers are grounded in this paper and cite their sources.
Background: For the past 30 years, our efforts have focused on the primary prevention of cancer through the use of a tumor marker combination assay.1However, an understanding has been difficult to achieve owing to the expansion of organspecific medicine.Patients with hepatitis B (HBV) and C virus (HCV) infections have about a 10-fold higher risk of liver cancer than individuals without viral hepatitis.We therefore focused on high-risk patients with viral hepatitis to study the effectiveness of a three-step liver cancer prevention program over the course of 10 years. Methods:The risk of cancer was assessed on the basis of the results of a dynamic tumor marker combination assay and conventional liver-function tests.The 406 subjects included 54 patients with chronic HBV hepatitis infection and 352 patients with chronic HCV hepatitis infection.Interventional studies of methods to predict and prevent the development of liver cancer were performed.The high risk subjects were treated with holistic methods that included dietary and life style change (dietary energy restriction) as well as a high dose of vitamin C, vitamin A, branched-chain amino acid granules and vitamin K2 as the first step.Intake of herbal medicine (Sun Advance) and detoxifying therapy constituted the second step, and local radiofrequency hyperthermia was the third step of liver cancer prevention program.Results: In the 406 patients with chronic hepatitis, the response to treatment to prevent the development of liver cancer in this 10-year survey was as follows: improvement was obtained in all 136 patients with mild hepatic fibrosis (F1) and 144 patients with moderate hepatic fibrosis F2.Among the 49 patients with advanced fibrosis F3, 34 improved, but 15 did not show no improvement.Among the 77 patients with cirrhosis (F4), 44 patients improved, while 33 patients showed no signs of improvement.Our three-step primary liver cancer prevention program thus effectively prevented the development of liver cancer in 99% of high-risk patients with chronic hepatitis.Liver cancer developed in only 3 patients (0.7%).Conclusion: Our three-step liver cancer prevention program effectively prevented the development of liver cancer in high-risk patients with chronic hepatitis.
No takes yet. Share an insight, caveat, or question.
Tsuneo Kobayashi (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: